Nutricog® Cognitive Performance
Complex has been Clinically Demonstrated to Improve Memory,
Increase Learning Rate and Capacity, Enhance Focus and
Concentration and Improve Overall Brain Function
MORRISTOWN, N.J., April 29,
2024 /PRNewswire/ -- PLT Health Solutions, Inc.
announced that it has received a license from the Natural and
Non-Prescription Health Products Directorate (NNHPD) of Health
Canada to market its ingredient Nutricog® Cognitive
Performance Complex to support cognitive health in
Canada. Nutricog is a
patented combination of
Haritaki (Terminalia chebula) and Boswellia
(Boswellia serrata) — standardized to gallic acid,
ellagic acid and amyrins. In a randomized, double-blind,
placebo-controlled clinical trial, users of Nutricog demonstrated
significant improvements compared to placebo across multiple
cognitive domains, including learning, memory, sustained attention,
working memory and executive function, where increases in cognitive
speed were seen concurrently with improvements in accuracy while
multitasking.
The list of claims approved by Health Canada for Nutricog
include:
- Helps to support cognitive health and/or brain function.
- Helps to support memory.
- Helps to support brain function
- Helps to support working memory and immediate recall
- Helps to support cognitive health and/or brain function.
- Helps to support (working) memory and immediate recall.
- Helps support cognitive function such as (selective)
attention
- Helps support cognitive function in older people
- Helps to support verbal and visual memory.
- Helps to support learning ability.
- Helps to support selective attention
- Helps to support working memory
- Helps with sleep quality, over time
According to Seth Flowerman,
President and CEO of PLT Health Solutions, the granting of an NHP
license for Nutricog by Health Canada is significant for what it
says about the science that supports Nutricog. "The broad range of
cognitive performance benefits demonstrated in our clinical study
make it ideal to support memory products, focus and attention
products, general brain products and more. Health Canada has a high bar for clinically supported
health claims, and we are proud of the quality of science
supporting this innovative and breakthrough ingredient," he
added.
Studies demonstrate broad-ranging cognitive support
A randomized, double-blind, placebo-controlled clinical trial
assessed Nutricog for its ability to impact learning and memory,
including attention, working memory, and decision-making. 100
healthy male and female subjects, aged 40-65 years, were provided
120 days of daily Nutricog or placebo and assessed for performance
improvements on the Rey Auditory Verbal Learning Test (RAVLT) and
the Cambridge Neuropsychological Test Automated
Battery (CANTAB), both well-established and validated tools
used to evaluate learning, memory, and other aspects of cognitive
performance. Other measures included the Athens Insomnia Scale and
biomarker testing for Brain-derived Neurotrophic Factor (BDNF).
Improvements in cognitive performance reported out from the
study included:
- A 1.4x improvement in Immediate Recall*^
- A 2.3x improvement in Delayed Recall*^
- A 1.6x improvement in Overall Learning*^
- A 2.7x improvement in Learning Rate*^
- A 11.5x improvement in Focus*^
- A 2.1x improvement in Recognition Index*^
- A 2x improvement in BDNF*^
^ These outcomes were statistically significant compared to
placebo in the clinical study
According to Jeremy Appleton, ND, Director of Medical and
Scientific Affairs PLT Health Solutions, the broad range of
benefits seen with the Nutricog clinical trial suggests a wide
range of products into which it can be formulated. "The power of
these clinical results is not just that Nutricog showed
significance in such a broad array of areas, but the amount of
change versus placebo that was demonstrated," he said. "The market
size and potential for knowledge workers alone—that includes over
100 million people— speaks to huge number of people who can benefit
from this ingredient," he added.
People of all age groups are tuning into the benefits of
improved cognitive health and performance The cognitive health
supplement market in the United
States alone is expected to grow at a compound annual
growth rate (CAGR) of 13.3% from 2023 to 2033, reaching a valuation
of US$16.8 billion by 2033
For more information on this ingredient, visit
www.plthealth.com/nutricog.
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG
ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT,
CURE, OR PREVENT ANY DISEASE.
Media Contact:
Mark
Falconer
Sciencewerks
Voice: 407-412-9705
E-mail: 376899@email4pr.com
Company Contact: Steve Fink
PLT Health Solutions, Inc.
Voice: 973-984-0900 x214
E-mail: 376899@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/plt-health-solutions-granted-broad-ranging-cognitive-health-claims-from-health-canada-based-on-clinical-study-results-302130029.html
SOURCE PLT Health Solutions
